Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 348640-02-8 | MDL No. : | MFCD02083277 |
Formula : | C14H12N2O2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NSNZZTVUYQKEMX-UHFFFAOYSA-N |
M.W : | 272.32 | Pubchem ID : | 1479966 |
Synonyms : |
|
Num. heavy atoms : | 19 |
Num. arom. heavy atoms : | 15 |
Fraction Csp3 : | 0.07 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 73.77 |
TPSA : | 60.34 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | Yes |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.93 cm/s |
Log Po/w (iLOGP) : | 2.14 |
Log Po/w (XLOGP3) : | 2.86 |
Log Po/w (WLOGP) : | 3.66 |
Log Po/w (MLOGP) : | 3.09 |
Log Po/w (SILICOS-IT) : | 1.77 |
Consensus Log Po/w : | 2.7 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.78 |
Solubility : | 0.0449 mg/ml ; 0.000165 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.79 |
Solubility : | 0.0446 mg/ml ; 0.000164 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -4.92 |
Solubility : | 0.00331 mg/ml ; 0.0000122 mol/l |
Class : | Moderately soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 2.56 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
93% | Stage #1: With sodium hydride In tetrahydrofuran; mineral oil at 0 - 20℃; for 0.5 h; Stage #2: at 0 - 20℃; |
1-(4-Methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine To a stirred solution of 7-azaindole (6.0 g, 50.0 mmol, 1.0 eq.) in THF (20 mL) was added NaH (60percent dispersion in mineral oil, 2.2 g, 66.0 mmol, 1.3 eq.) at 0° C. The reaction mixture was allowed to warm to rt and stirred for 30 min. After cooling to 0° C., TsCl (11.6 g, 2.1 mmol, 1.2 eq.) was added to the reaction mixture and it was stirred at rt overnight. The reaction mixture was quenched with water and extracted with EtOAc. The organic layer was washed with brine, dried over Na2SO4 and evaporated to dryness. The residue was purified by column chromatography (EtOAc gradient in hexane) to give 1-(4-methylbenzenesulfonyl)-1H-pyrrolo[2,3-b]pyridine (Intermediate 1a) as a white solid (12.8 g; yield: 93percent; UPLC purity: 100percent). |
87% | With sodium hydroxide In water at 20℃; for 4 h; | To a mixture of 209-1 (45.0 g, 381.4 mmol), para-toluenesulfonyl chloride (80.1 g, 421.6 mmol) and a catalytic amount of tetrabutyl ammonium bromide (TBABr) in toluene (540 ml) was added aq. NaOH (288.0 g in 900 ml water, 7.2 mol). The biphasic solution was stirred at ambient temperature for 4 h, and then extracted twice with toluene. The organic phase was dried over anhydrous Na2SO4 and concentrated. The crude product was triturated in ethyl acetate/petroleum ether (V:V=1:20) and filtrated to afford the compound 209-2 (90g, 87percent yield). MS-ESI: m/z=273.1 [M+1]+ |
330 g | With tetrabutylammomium bromide; sodium hydroxide In water; toluene at 20 - 30℃; | Example 1B: 1-tosyl-1H-pyrrolo[2,3-b]pyridine. [0286] A flask was charged with 1H-pyrrolo[2,3-b]pyridine (350.0 g, 2.963 mol) and toluene (2800 mL), followed by 4-toluenesulfonyl chloride (626.9 g, 3.288 mol) and TBAB (9.55 g, 0.0296 mol) in toluene (2800 mL). An aqueous solution of 25percent NaOH (1185.2 g) was added dropwise into the mixture while controlling the temperature between 20 —30 °C. The mixture was stirred at 20 —25 °C overnight. Water (700 ml) and THF (1750 ml) were added to the mixture and aqueous phase was extracted with THF (2 x 1750 ml). The organic phase was washed with brine (2 x 1750 mL) and dried over Mg2SO4. The organic phase was then concentrated to 700 — 850 mL and filtered. The cake was then washed with n-heptane (3 x 350 ml). After drying, 330 g of 1-tosyl-1H-pyrrolo[2,3-b]pyridine was obtained. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
58% | Stage #1: With n-butyllithium In tetrahydrofuran; hexane at -78℃; for 1.33333 h; Stage #2: With 1,2-dibromo-1,1,2,2-tetrachloroethane In tetrahydrofuran; hexane at -78 - 20℃; |
A solution of 209-2 (50.0 g, 183.8 mmol) in dry THF cooled to -78° C. and n-BuLi (81 ml, 2.5 M in hexane) was added over 20 minutes. The resulted solution was maintained at -78° C. for 1 h, and then a solution of BrCl2CCCl2Br (71.0 g, 220.5 mmol) in dry THF was added. The mixture was stirred -78° C. for 30 min and allowed to warm slowly to room temperature. The solvent was removed under vacuum and the residue was partitioned between EtOAc and water. The organic layer was dried over anhydrous Na2SO4 and concentrated. The crude product was purified by column chromatography (5percent ethyl acetate in petroleum ether to 20percent ethyl acetate in petroleum ether as the eluent) to afford 209-3 (37 g, 58percent yield). MS-ESI: m/z=351.0 [M+1]+ |
[ 896722-51-3 ]
6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.95
[ 896722-50-2 ]
6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.93
[ 348640-07-3 ]
4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.92
[ 880769-95-9 ]
3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.90
[ 1198416-32-8 ]
2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.88
[ 896722-51-3 ]
6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.95
[ 896722-50-2 ]
6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.93
[ 348640-07-3 ]
4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.92
[ 880769-95-9 ]
3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.90
[ 1198416-32-8 ]
2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.88
[ 896722-51-3 ]
6-Methyl-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.95
[ 896722-50-2 ]
6-Chloro-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.93
[ 348640-07-3 ]
4-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.92
[ 880769-95-9 ]
3-Bromo-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.90
[ 1198416-32-8 ]
2-Bromo-1-tosyl-1H-pyrrolo[2,3-b]pyridine
Similarity: 0.88